医疗保险数据中重症监护与机械通气编码的验证
本研究为回顾性队列研究,将46家美国医院参与APACHE Outcomes的62,451例≥65岁ICU患者数据与Medicare Provider Analysis and Review(MPAR)记录按性别、出生日期、医院和入院日期匹配,80.1%匹配成功。MPAR中ICU或冠心病监护病房收费编码覆盖了除2.7%以外的APACHE Outcomes ICU患者。APACHE Outcomes中37.0%接受机械通气,而MPAR仅24.1%;MPAR机械通气操作编码特异性96.0%(95%CI 95.8-96.2),敏感性仅58.4%(95%CI 57.7-59.1),阳性预测值89.6%(95%CI 89.1-90.1),阴性预测值79.7%(95%CI 79.4-80.1)。在有机械通气编码的患者中,MPAR高估了机械通气持续时间>96小时的比例(MPAR 36.6% vs APACHE Outcomes 27.3%)。医院出院状态(存活或死亡)不一致仅占所有链接记录的0.47%(κ=1.00)。
要点
- MPAR机械通气编码敏感性仅58.4%(95%CI 57.7-59.1),特异性96.0%(95%CI 95.8-96.2),阳性预测值89.6%(95%CI 89.1-90.1),阴性预测值79.7%(95%CI 79.4-80.1)。
- APACHE Outcomes中37.0%的ICU患者接受机械通气,而MPAR仅记录24.1%,提示基于MPAR的机械通气使用率估计可能应上调。
- 在有机械通气编码的患者中,MPAR高估机械通气持续时间>96小时的比例(36.6% vs APACHE Outcomes 27.3%)。
- MPAR中ICU或冠心病监护病房收费编码覆盖了除2.7%以外的APACHE Outcomes ICU患者,ICU入住识别较完整。
- 医院出院状态(存活或死亡)不一致仅0.47%(κ=1.00),MPAR住院死亡率信息可靠。
适用人群与场景
- 美国46家参与APACHE Outcomes的医院中,≥65岁且能与MPAR住院记录链接的ICU患者,数据覆盖2009年1月1日至2012年9月30日。
研究设计与关键结果
- 回顾性队列研究,链接APACHE Outcomes与MPAR数据,62,451例中80.1%匹配成功。
- APACHE Outcomes中37.0%接受机械通气,MPAR中24.1%;MPAR机械通气编码敏感性58.4%(95%CI 57.7-59.1),特异性96.0%(95%CI 95.8-96.2),阳性预测值89.6%(95%CI 89.1-90.1),阴性预测值79.7%(95%CI 79.4-80.1)。
- 在有机械通气编码的患者中,MPAR报告机械通气持续时间>96小时的比例为36.6%,APACHE Outcomes为27.3%。
- MPAR中ICU或冠心病监护病房收费编码覆盖了除2.7%以外的APACHE Outcomes ICU患者。
- 医院出院状态(存活或死亡)不一致仅占所有链接记录的0.47%(κ=1.00)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 基于MPAR数据估计美国机械通气使用率时,因编码敏感性仅58.4%,作者认为估计值可能应上调。
- MPAR住院死亡率数据可靠(不一致仅0.47%,κ=1.00),可用于ICU患者住院死亡率评估;但机械通气识别敏感性有限,可能漏掉约四成实际接受机械通气的患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the reliability of codes relevant to critically ill patients in administrative data.
DESIGN: Retrospective cohort study linking data from Acute Physiology and Chronic Health Evaluation Outcomes, a clinical database of ICU patients with data from Medicare Provider Analysis and Review. We linked data based on matching for sex, date of birth, hospital, and date of admission to hospital.
SETTING: Forty-six hospitals in the United States participating in Acute Physiology and Chronic Health Evaluation Outcomes.
PATIENTS: All patients in Acute Physiology and Chronic Health Evaluation Outcomes greater than or equal to 65 years old who could be linked with hospitalization records in Medicare Provider Analysis and Review from January 1, 2009, through September 30, 2012.
MEASUREMENTS AND MAIN RESULTS: Of 62,451 patients in the Acute Physiology and Chronic Health Evaluation Outcomes dataset, 80.1% were matched with data in Medicare Provider Analysis and Review. All but 2.7% of Acute Physiology and Chronic Health Evaluation Outcomes ICU patients had either an ICU or coronary care unit charge in Medicare Provider Analysis and Review. In Acute Physiology and Chronic Health Evaluation Outcomes, 37.0% received mechanical ventilation during the ICU stay versus 24.1% in Medicare Provider Analysis and Review. The Medicare Provider Analysis and Review procedure codes for mechanical ventilation had high specificity (96.0%; 95% CI, 95.8-96.2), but only moderate sensitivity (58.4%; 95% CI, 57.7-59.1), with a positive predictive value of 89.6% (95% CI, 89.1-90.1) and negative predictive value of 79.7% (95% CI, 79.4-80.1). For patients with mechanical ventilation codes, Medicare Provider Analysis and Review overestimated the percentage with a duration greater than 96 hours (36.6% vs 27.3% in Acute Physiology and Chronic Health Evaluation Outcomes). There was discordance in the hospital discharge status (alive or dead) for only 0.47% of all linked records (κ = 1.00).
CONCLUSIONS: Medicare Provider Analysis and Review data contain robust information on hospital mortality for patients admitted to the ICU but have limited ability to identify all patients who received mechanical ventilation during a critical illness. Estimates of use of mechanical ventilation in the United States should likely be revised upward.
参考来源
- Wunsch H, Kramer A, Gershengorn HB, et al. Validation of Intensive Care and Mechanical Ventilation Codes in Medicare Data. Crit Care Med. 2017. PMID: 28403118. doi:10.1097/CCM.0000000000002316
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。